Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation

Annals of Neurology

Volumn 46, Issue 3, 1999, Pages 313-318

  Inoue, Ken ^a,b   Tanabe, Yuzo ^c   Lupski, James R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOPIGMENTATION; MYELIN DEFICIENCY; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; WAARDENBURG SYNDROME;

ALLELES; CENTRAL NERVOUS SYSTEM; CHILD; DNA-BINDING PROTEINS; FEMALE; HIGH MOBILITY GROUP PROTEINS; HUMANS; MAGNETIC RESONANCE IMAGING; MYELIN PROTEINS; PERIPHERAL NERVOUS SYSTEM; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 0032833425     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7     Document Type: Article

References (37)

1. Colello RJ, Pott U. Signals that initiate myelination in the developing mammalian nervous system. Mol Neurobiol 1997;15: 83-100
2. Schreiber J, Enderich J, Sock E, et al. Redundancy of class III POU proteins in the oligodendrocyte lineage. J Biol Chem 1997;272:32286-32293
3. Kuhlbrodt K, Herbarth B, Sock E, et al. Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem 1998;273:16050-16057
4. Kuhlbrodt K, Herbarth B, Sock E, et al. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 1998;18: 237-250
5. Bondurand N, Kobetz A, Pingault V, et al. Expression of the SOX10 gene during human development. FEBS Lett 1998;432: 168-172
6. Herbarth B, Pingault V, Bondurand N, et al. Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci USA 1998;95:5161-5165
7. Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 1998;18:60-64
8. Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998;18:171-173
9. Lane PW, Liu HM. Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered 1984;75: 435-439
10. Sambrook J, Fritsch E, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989
11. Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382-384
12. Timmerman V, De Jonghe P, Ceuterick C, et al. Novel missense mutation in the early growth response 2 gene associated with a Dejerine-Sottas syndrome phenotype. Neurology 1999; 52:1827-1832
13. Osaka H, Kawanishi C, Inoue K, et al. Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males. Biochem Biophys Res Commun 1995;215:835-841
14. Roa BB, Warner LE, Garcia CA, et al. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Hum Mutat 1996;7:36-45
15. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A: association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101
16. Bergoffen J, Scherer SS, Wang S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262: 2039-2042
17. Inoue K, Osaka H, Imaizumi K, et al. Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann Neurol 1999; 45:624-632
18. Shaffer LG, Kennedy GM, Spikes AS, Lupski JR. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am J Med Genet 1997;69:325-331
19. Henikoff S, Henikoff JG. Protein family classification based on searching a database of blocks. Genomics 1994;19:97-107
20. Lupski JR. Charcot-Marie-Tooth disease: lessons in genetic mechanisms. Mol Med 1998:4:3-11
21. Osaka H, Kawanishi C, Inoue K, et al. Pelizaeus-Merzbacher disease: three novel mutations and implication for locus heterogeneity. Ann Neurol 1999;45:59-64
22. Caro PA, Marks HG. Magnetic resonance imaging and computed tomography in Pelizaeus-Merzbacher disease. Magn Reson Imaging 1990;8:791-796
23. Kuhlbrodt K, Schmidt C, Sock E, et al. Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J Biol Chem 1998;273:23033-23038
24. Madden SL, Cook DM, Morris JF, et al. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 1991;253:1550-1553
25. Jensen NA, Pedersen KM, Celis JE, West MJ. Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6. J Clin Invest 1998;101:1292-1299
26. Jaegle M, Mandemakers W, Broos L, et al. The POU factor Oct-6 and Schwann cell differentiation. Science 1996;273: 507-510
27. Kwok C, Weller PA, Guioli S, et al. Mutations in SOX9, the gene responsible for campomelic dysplasia and autosomal sex reversal. Am J Hum Genet 1995;57:1028-1036
28. Topilko P, Schneider-Maunoury S, Levi G, et al. Krox-20 controls myelination in the peripheral nervous system. Nature 1994;371:796-799
29. Kioussi C, Gross MK, Gruss P. Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 1995;15:553-562
30. Farrer LA, Arnos KS, Asher JH Jr, et al. Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes. Am J Hum Genet 1994;55:728-737
31. Tassabehji M, Read AP, Newton VE, et al. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat Genet 1993;3:26-30
32. Hofstra RMW, Osinga J, Tan-Sindhunata G, et al. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996;12:445-447
33. Edery P, Attié T, Amiel J, et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996;12:442-444
34. Edery P, Lyonnet S, Mulligan LM, et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 1994;367: 378-380
35. Romeo G, Ronchetto P, Luo Y, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994;367:377-378
36. Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994;79:1257-1266
37. Watanabe A, Takeda K, Ploplis B, Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet 1998;18:283-286